Dylan Marsh

Dylan Marsh

Higher Degree by Research Candidate

School of Biomedicine

Faculty of Health and Medical Sciences


BHSc (Hons), University of Adelaide, 2016.
PhD Candidate in Medicine (Pharmacology), University of Adelaide, 2017-present.

My research focuses on the use of phytocannabinoids, medicinal cannabis extracts and other natural products as neuroprotective, anti-amyloid and anti-inflammatory agents, with a focus on Alzheimer's Disease and chemotherapy-induced gastrointestinal inflammation and mucosal damage.

  • Journals

    Year Citation
    2022 Marsh, D. T., & Smid, S. D. (2022). The semi-synthetic flavonoid 2',3',4'-trihydroxyflavone (2-D08) inhibits both SN-38- and cytokine-evoked increases in epithelial barrier permeability in an <i>in vitro</i> intestinal mucositis model.. Food & function.
    DOI
    2020 Marsh, D. T., & Smid, S. D. (2020). Cannabis Phytochemicals: A Review of Phytocannabinoid Chemistry and Bioactivity as Neuroprotective Agents. AUSTRALIAN JOURNAL OF CHEMISTRY, 74(6), 388-404.
    DOI Scopus2 WoS2
    2017 Marsh, D., Das, S., Ridell, J., & Smid, S. (2017). Structure-activity relationships for flavone interactions with amyloid β reveal a novel anti-aggregatory and neuroprotective effect of 2′,3′,4′-trihydroxyflavone (2-D08). Bioorganic and Medicinal Chemistry, 25(14), 3827-3834.
    DOI Scopus29 WoS27 Europe PMC7

Connect With Me
External Profiles